Heart rate turbulence analysis in female patients with fibromyalgia by Dursun, Huseyin et al.
Heart rate turbulence analysis in female patients
with fibromyalgia
Huseyin Dursun,I,* Ersel Onrat,II Emine Ercan,II Umit Secil Demirdal,III Alaettin Avsar,II Umit Dundar,IV
Ozlem Solak,IV Hasan ToktasIV
IDokuz Eylul University, Faculty of Medicine, Department of Cardiology, Izmir, Turkey. IIAfyon Kocatepe University, Faculty of Medicine, Department of
Cardiology, Afyonkarahisar, Turkey. IIIKatip Celebi University, Department of Physical Medicine and Rehabilitation, Izmir, Turkey. IVAfyon Kocatepe
University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Afyonkarahisar, Turkey.
OBJECTIVE: Fibromyalgia is characterized by diffuse musculoskeletal pain and discomfort. There are several
reports regarding autonomic nervous system dysfunction in patients with fibromyalgia. Heart rate turbulence is
expressed as ventriculophasic sinus arrhythmia and has been considered to reflect cardiac autonomic activity.
Heart rate turbulence has been shown to be an independent and powerful predictor of sudden cardiac death in
various cardiac abnormalities. The aim of this study is to determine whether heart rate turbulence is changed in
female patients with fibromyalgia compared with healthy controls.
METHODS: Thirty-seven female patients (mean age, 40±11 years) with fibromyalgia, and 35 age- and sex-
matched healthy female control subjects (mean age, 42±9 years) were included. Twenty-four hours of
ambulatory electrocardiography recordings were collected for all subjects, and turbulence onset and turbulence
slope values were automatically calculated.
RESULTS: The baseline clinical characteristics of the two groups were similar. There were no significant differences
in turbulence onset and turbulence slope measures between patients and control subjects (turbulence onset:
 1.648±1.568% vs.  1.582±1.436%, p=0.853; turbulence slope: 12.933±5.693 ms/RR vs. 13.639±2.505 ms/RR,
p=0.508). Although body mass index was negatively correlated with turbulence slope (r=  0.258, p=0.046), no
significant correlation was found between body mass index and turbulence onset (r= 0.228, p=0.054).
CONCLUSION: To the best of our knowledge, this is the first study to evaluate heart rate turbulence in patients
with fibromyalgia. It appears that heart rate turbulence parameters reflecting cardiac autonomic activity are
not changed in female patients with fibromyalgia.
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’ INTRODUCTION
Fibromyalgia (FM) is an idiopathic disease characterized
by widespread chronic pain and discomfort (1). Along with
the pivotal symptom of pain, FM is accompanied by fatigue,
cognitive dysfunction, mood disorder (2), nonrestorative
sleep (3), and variable somatic symptoms (4). Although the
etiology of the disease is not fully understood, many studies
(5–7) suggest that autonomic nervous system (ANS) dys-
function plays a role in the disease process.
Heart rate turbulence (HRT), which reflects the response of the
heart rate to a premature ventricular beat (PVB), is a noninvasive
tool used to assess the autonomic and reflex modulations of
cardiac function. HRT impairment reflects cardiac autonomic
dysfunction, particularly impaired baroreflex sensitivity and
reduced parasympathetic activity (8). It has been shown that
HRT is an independent and powerful predictor of mortality and
sudden cardiac death in various cardiac abnormalities (9).
However, there is limited knowledge on HRT behavior in
patients with FM. The main goal of this study was to evaluate
cardiac autonomic functions in female patients with FM using
HRT analysis compared with healthy subjects.
’ MATERIALS AND METHODS
Fifty-one patients with FM who were already being followed
by the Department of Physical Medicine and Rehabilitation at
Afyon Kocatepe University and 53 age- and sex-matched
healthy controls between 1 January 2006 and 31 December 2013DOI: 10.6061/clinics/2015(04)13
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were enrolled in this study. The diagnosis of FM was based on
the American College of Rheumatology 1990 criteria (10).
Patients with prior myocardial infarction, hemodynami-
cally unstable valvular heart disease, congenital heart
disease, atrial fibrillation, bundle branch block, an implanted
pacemaker, hypertension, diabetes mellitus, a prior cerebro-
vascular accident, chronic obstructive pulmonary disease,
severe liver or renal insufficiency, or malignancy or patients
using cardio-active drugs (especially beta blockers and/or
antiarrhythmic drugs) were excluded from the study.
Smokers were also excluded from both groups.
All participants' physical examinations and resting 12-lead
electrocardiograms were normal. They underwent 24-hr
Holter electrocardiogram monitoring. HRT could not be
calculated in 14 patients with FM and in 18 controls that did
not have any PVB in their Holter recordings. Therefore,
14 patients with FM and 18 control subjects were excluded
from the study. HRT was calculated in 37 patients with FM
and 35 control subjects who had at least one PVB in their
Holter recordings. All subjects gave their informed consent
prior to inclusion in the study, and all examinations were
performed by the Afyon Kocatepe University Department
of Cardiology.
HRT Analysis
HRT parameters, turbulence onset (TO), and turbulence
slope (TS) were automatically calculated by a computer
program (HRT View, Version 0.60-0.1 Software Program,
Munich, Germany). Abnormal data found between 5 sinus
beats before and 15 sinus beats after a PVB as well as visually
observed artifacts that the program accepted as a normal
PVB were excluded from the analysis. Measurements of HRT
were calculated by the original method performed by
Schmidt et al. (9). TO, which is a measure of the early sinus
acceleration after a PVB, is expressed as a percentage and is
calculated with the following formula:
[(RR1 + RR2) - (RR-2 + RR-1)] / (RR-2 + RR-1) x 100,
where RR1 and RR2 are the first and second sinus RR
intervals after the PVB, and RR-1 and RR-2 are the first and
the second sinus RR intervals preceding the PVB.
TS is an indicator of late sinus deceleration after PVB and
is defined as the maximum positive slope of a regression line
assessed over any sequence of five subsequent RR intervals
within the first 20 sinus rhythm intervals after PVB (11). A
TOZ0% and a TSr2.5 msec/RR were considered abnormal.
TO was separately calculated for all PVBs and then
averaged, whereas TS was calculated based on an averaged
local tachogram.
Statistical Analysis
Statistical analysis was performed using SPSS for Windows
version 15.0 (SPSS Inc., Chicago, IL, USA). Normally
distributed continuous data were expressed as the mean±
standard deviation (SD). Comparisons between independent
groups were performed using Student's t test. To define the
correlation between body mass index (BMI) and HRT
measures, Pearson's correlation analysis was applied. A
P-value o0.05 was considered statistically significant.
’ RESULTS
There were no significant differences between the patient
and control groups with regard to age, heart rate, BMI, and
systolic and diastolic blood pressures (Table 1). None of the
participants presented any sustained or nonsustained ventri-
cular tachyarrhythmia as observed with 24-h ambulatory ECG
monitoring. HRT parameters, TO and TS did not significantly
differ between the two groups, as shown in Figure 1.
The correlation analysis revealed a weak negative correla-
tion between BMI and TS (r = -0.258, p = 0.046). However,
there was no significant correlation between BMI and TO
(r = 0.228, p = 0.054) (Figure 2).
Table 1 - Clinical characteristics of the patient and control groups. Data are shown as n or the mean±SD;
FM-fibromyalgia.
FM (n=37) Control (n = 35) P-value
Age (years) 40±11 42±9 0.212
Heart rate (/min) 74±7 76±10 0.361
Systolic blood pressure (mmHg) 132±12 128±16 0.760
Diastolic blood pressure (mmHg) 82±10 78±12 0.250
Body mass index (kg/m2) 22.97±1.66 22.13±2.20 0.070
Figure 1 - Turbulence Onset (A) and Turbulence Slope (B) values of the two study groups with confidence intervals.
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’ DISCUSSION
The major finding of this study is that HRT measures of
female patients with FM are not different from healthy
control subjects. Autonomic dysfunction has been suggested
to increase the risk for cardiovascular events and mortality (12).
Although the data are not fully understood regarding the risk
of cardiovascular disease in women with FM, many studies
suggest ANS involvement in this disease. It is postulated that
abnormal overactivity of the sympathetic system at rest and
abnormal autonomic responses to sympathetic challenges
could explain symptoms related to FM, such as fatigue,
decreased pain threshold, anxiety, and intestinal irritability (13).
Backman et al. (5) were the first to observe striated muscle
sympathetic hyperactivity in this disease. They found a
lower basal muscle relaxation rate, which increased during
sympathetic blockade. The authors suggested that increased
muscle sympathetic nerve activity is a possible mechanism.
However, Elam et al. (14) found no difference in baseline
sympathetic activity between FM patients and controls when
recording muscle sympathetic activity by microneurography.
However, orthostatic intolerance and deranged sympathetic
response to an active orthostatic stress (15–17) were detected
in patients with FM.
Cardiovascular responses in patients with FM during
exercise have also been examined. After a maximal treadmill
test, the chronotropic reserve was found to be significantly
lower in women with FM than in healthy controls. Signi-
ficant reductions in heart rate recovery at 1 minute and 2
minutes after exercise (18) were also observed, suggesting an
inability of the parasympathetic system to recover.
Furthermore, Martinez-Lavin et al. (19) reported that
patients with FM have diminished 24-hour heart rate
variability (HRV) due to an exaggerated sympathetic modula-
tion of the sinus node. In another study (20), these authors also
demonstrated that FM patients have an aberrant circadian
rhythm of autonomic nervous tone, with persistent nocturnal
sympathetic hyperactivity. They suggested that this may be
the cause of sleep disorders in FM. These studies support
the proposition that patients with FM have a decreased
sympathetic response to stress.
In our study, we used HRT measurements, TO and TS to
assess cardiac autonomic functions because of the contro-
versial results of previous studies assessing cardiac auto-
nomic activity using different methods. The heart is richly
innervated by afferent and efferent vagal and sympathetic
fibers and is susceptible to autonomic influences (21).
Increased sympathetic and decreased vagal tone can cause
arrhythmogenesis. Efferent cardiac autonomic activity is
largely under the control of baroreceptor and baroreflex
sensitivities (22), which are correlated with cardiac arrhyth-
mias. HRT is an indirect cardiac autonomic function test that
estimates heart rate fluctuations resulting from the stimula-
tion of the baroreceptor arc after a single PVB. HRT is
strongly correlated with spontaneous baroreceptor reflex
sensitivity (BRS) and may be used instead of BRS (23). The
European Society of Cardiology (24) considers HRT a marker
of vagal activity and an independent indicator of total
mortality. TO and TS values have strong correlations with
some of the heart rate variability (HRV) parameters, including
standard deviation of all normal sinus RR intervals (SDNN)
and root mean squared differences of successive RR intervals
(RMSSD) (25).
Most of the studies determined that HRT, baroreflex
sensitivity and HRV were present in the same diseases.
However, they may not always change in the same disease.
For example, Bigger et al. (26) have shown that altered HRV
has been observed after myocardial infarction, and baroreflex
sensitivity and HRT were found to be normal in the same
group. Another study (27) also showed that in the same
patient group after myocardial infarction, HRV indices
increased, but HRT parameters did not change. As a result,
HRT and HRV indices may indicate different aspects of the
ANS (26) and might provide prognostic information of
incremental value.
In previous studies, HRV has been determined in patients
with FM; however, HRT has not yet been investigated. Our
study is the first HRT study in patients with FM. HRV was
Figure 2 - Pearson correlation analysis of variables. A) Turbulence Onset and Body Mass Index; B) Turbulence Slope and Body Mass Index.
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found to be decreased (19,20) in patients with FM. However,
in our study, HRT did not appear to be altered in patients
with FM. This may be partly due to methodological
discrepancies or may possibly reveal heterogeneity in cardiac
ANS in patients with FM. Constitutional and genetic factors
also may play role. The physiological mechanisms under-
lying the various measures of HRV and HRT are different.
HRV describes variations in both instantaneous heart rate
and RR intervals and can reflect the coupling between the
ANS and the sinoatrial node. HRT reflects the physiological
biphasic response of the sinus node to PVBs, most likely
because of a baroreflex arc. There is a modest correlation
between HRT parameters and HRV measures.
Previous studies have demonstrated a relationship
between increased BMI and FM symptoms (28,29), which
may be due to physical or psychological factors, and
suggested that weight loss may improve physical function-
ing in patients with FM. Furthermore, in one study, obesity
(30) was found to be a risk factor for the development of FM.
In our study, BMI values in the patient and control groups
were similar. However, there are few reports evaluating the
association between BMI and HRT. In one of these studies,
Sarikaya et al. (31) demonstrated that TO and TS were
impaired in young obese patients without comorbidities,
suggesting impaired parasympathetic activity. We also found
a weak negative correlation between BMI and TS; however,
no significant correlation was detected between BMI and TO.
The main limitation of our study is the small sample size
because a small sample size results in low statistical power
for equivalency testing; thus, negative results may simply be
due to chance. The lack of a reference method for studying
autonomic dysfunction that could be used as a validation of
the method in this study is another limitation. However,
HRT is known to be a useful tool for assessing autonomic
cardiac functions. Unfortunately, this type of data, collected
from 24-hr Holter recordings, may not be the best for
studying cardiac autonomic responses in a clinically defined
group. The absence of a power spectral analysis of heart rate
to a tightly controlled provocative test instead of long-term
recordings obtained in circumstances that are difficult to
control is another limitation of this study.
In conclusion, the HRT parameters, which determine
cardiac autonomic dysfunction, did not appear to be altered
in female patients with FM. We believe that comprehensive
cardiac autonomic function studies with a larger number of
participants should be performed in this disease.
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